Addus Homecare (NASDAQ:ADUS) Sets New 52-Week High at $78.24
Addus Homecare Co. (NASDAQ:ADUS) reached a new 52-week high during trading on Tuesday . The company traded as high as $78.24 and last traded at $77.26, with a volume of 26381 shares trading hands. The stock had previously closed at $77.69.
A number of research analysts have commented on the stock. Zacks Investment Research upgraded shares of Gerdau from a “sell” rating to a “hold” rating in a research note on Monday, May 13th. BMO Capital Markets assumed coverage on shares of Encompass Health in a research note on Thursday, June 27th. They set an “outperform” rating and a $72.00 price objective on the stock. Raymond James assumed coverage on shares of Adverum Biotechnologies in a research note on Thursday, June 13th. They set a “market perform” rating on the stock. BidaskClub downgraded shares of Xencor from a “sell” rating to a “strong sell” rating in a research note on Tuesday, June 11th. Finally, ValuEngine upgraded shares of XPO Logistics from a “strong sell” rating to a “sell” rating in a research note on Thursday, April 4th. One equities research analyst has rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $77.88.
The firm has a market capitalization of $1.02 billion, a P/E ratio of 45.60, a price-to-earnings-growth ratio of 2.36 and a beta of -0.09. The firm has a fifty day simple moving average of $73.16. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.87 and a quick ratio of 2.87.
In other Addus Homecare news, CFO Brian Poff sold 814 shares of the stock in a transaction on Friday, May 10th. The shares were sold at an average price of $67.96, for a total transaction of $55,319.44. Following the sale, the chief financial officer now directly owns 18,241 shares of the company’s stock, valued at $1,239,658.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Mark L. First sold 440,000 shares of the stock in a transaction on Tuesday, June 11th. The stock was sold at an average price of $74.08, for a total transaction of $32,595,200.00. Following the sale, the director now directly owns 19,151 shares in the company, valued at $1,418,706.08. The disclosure for this sale can be found here. Insiders have sold 460,814 shares of company stock worth $34,061,919 over the last three months. 34.80% of the stock is owned by corporate insiders.
Hedge funds have recently added to or reduced their stakes in the stock. Marshall Wace North America L.P. acquired a new stake in shares of Addus Homecare in the 1st quarter worth about $34,000. Bank of Montreal Can increased its holdings in shares of Addus Homecare by 58.9% in the 1st quarter. Bank of Montreal Can now owns 545 shares of the company’s stock worth $35,000 after acquiring an additional 202 shares during the period. South Dakota Investment Council acquired a new stake in shares of Addus Homecare in the 1st quarter worth about $83,000. BNP Paribas Arbitrage SA increased its holdings in shares of Addus Homecare by 9,077.3% in the 1st quarter. BNP Paribas Arbitrage SA now owns 2,019 shares of the company’s stock worth $128,000 after acquiring an additional 1,997 shares during the period. Finally, NumerixS Investment Technologies Inc acquired a new stake in shares of Addus Homecare in the 1st quarter worth about $138,000. 98.90% of the stock is currently owned by institutional investors and hedge funds.
About Addus Homecare (NASDAQ:ADUS)
Addus HomeCare Corporation provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates in three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living.
Featured Story: How to track put option volume
Receive News & Ratings for Addus Homecare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus Homecare and related companies with MarketBeat.com's FREE daily email newsletter.